Ausgabe 2/2006
Inhalt (17 Artikel)
Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer
G. Pentheroudakis, E. Razis, A. Athanassiadis, N. Pavlidis, G. Fountzilas
Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors
Masahiro Tsuboi, Thierry Le Chevalier
Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
Mónica Fernández-Sánchez, Armando Gamboa-Dominguez, Norma Uribe, Ana Cristina García-Ulloa, Diana Flores-Estrada, Myrna Candelaria, Oscar Arrieta
Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer
Cem H. Misirliogluo, Handan Erkal, Yesim Elgin, Isil Ugur, Kadri Altundag
Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC)
F. Yang, P. Shi, X. Xi, S. Yi, H. Li, Q. Sun, M. Sun
Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer
Yasunori Hashiguchi, Hiroshi Tsuda, Christina A. Bandera, Sadako Nishimura, Takeshi Inoue, Naoki Kawamura, Ross S. Berkowitz, Samuel C. Mok
The value of serum bcl-2 levels in advanced epithelial ovarian cancer
Faruk Tas, Derya Duranyildiz, Hilal Oguz, Hakan Camlica, Vildan Yasasever, Erkan Topuz
Pelvic exenteration for recurrent or persistent cervical cancer
M. A. Terán-Porcayo, I. Zeichner-Gancz, R. A. C. Gomez del-Castillo, A. Beltrán-Ortega, G. Solorza-Luna
Primary extranodal lymphomas of gastrointestinal localizations
B. Mihaljević, R. Nedeljkov-Jančić, V. Vujičić, D. Antić, S. Janković, N. Čolović
Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer
Wesam A. Nasif, Mahmoud Lotfy, Ibrahim H. El-Sayed, Ayman El-Meghawry El-Kenawy, Mohamed El-Shahat, Nabil Gad El-Hak
Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro
M. Waheed Roomi, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki, Matthias Rath
Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas
K. Mystakidou, E. Katsouda, A. Linou, E. Parpa, V. Kouloulias, V. Nikolaou, L. Vlahos
Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients
Rony M. Abou-Jawde, Janice Reed, Megan Kelly, Esteban Walker, Steven Andresen, Rachid Baz, Mary Ann Karam, Mohamad Hussein
Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells
Reza Mahdian, Parviz Kokhaei, Hossein Motieian Najar, Katja Derkow, Aniruddha Choudhury, Håkan Mellstedt
Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)
Magdalena Adde, Gunilla Enblad, Hans Hagberg, Christer Sundström, Anna Laurell
Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma
Agustín Avilés, Natividad Neri, M. Jesús Nambo, Judith Huerta-Guzman, Sergio Cleto
Uterine choriocarcinoma in a postmenopausal woman
U. Mukherjee, V. Thakur, D. Katiyar, Hari K. Goyal, D. Pendharkar